GlassScriptPhysician profile
Da Wei Liao
NPI 1053379263
$309,532.49
in general payments reported to CMS, 2019-2025
64 companies · $51K in 2025
The $51K reported for 2025 was more than what 98% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $29K · 2021: $57K · 2022: $54K · 2023: $50K · 2024: $41K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $98K · Consulting Fee: $23K · Food and Beverage: $14K · Travel and Lodging: $7,504 · Education: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $97,504.80 |
| Consulting Fee | $22,568.50 |
| Food and Beverage | $13,992.25 |
| Travel and Lodging | $7,504.43 |
| Education | $520.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $87,893.82 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $64,580.68 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Genzyme Corporation | $39,069.43 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $35,484.07 | 2019-2025 | Dupixent |
| Grifols USA, LLC | $27,526.15 | 2019-2025 | Prolastin-C Liquid |
| Allergan, INC. | $9,151.30 | 2019-2020 | |
| Nestle Healthcare Nutrition INC. | $8,594.00 | 2020-2023 | |
| Grifols Shared Services North America, INC. | $7,968.27 | 2019-2025 | Prolastin-C Liquid |
| United Therapeutics Corporation | $7,749.59 | 2021-2025 | Tyvaso, Tyvaso |
| Genentech USA, INC. | $4,182.83 | 2019-2025 | Xolair, Pulmozyme, Esbriet |
| Regeneron Pharmaceuticals, INC. | $3,672.00 | 2024 | Dupixent |
| Stryker Corporation | $1,713.00 | 2020 | |
| Viiv Healthcare Company | $1,600.00 | 2019 | |
| Mylan Specialty L.P. | $1,358.74 | 2019-2024 | Yupelri |
| Actelion Pharmaceuticals US, INC. | $1,134.36 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $868.30 | 2019-2025 | Zerbaxa, Recarbrio, Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $730.30 | 2019-2025 | Ofev, Jascayd |
| Intuitive Surgical, INC. | $606.54 | 2024 | |
| Insmed, INC. | $523.00 | 2019-2025 | Arikayce |
| Mallinckrodt Hospital Products INC. | $479.81 | 2021-2025 | Acthar |
| Electromed, INC. | $383.02 | 2019-2025 | Smartvest |
| Novartis Pharmaceuticals Corporation | $324.63 | 2019-2025 | |
| Harmony Biosciences LLC | $300.87 | 2021-2024 | Wakix |
| Viatris Specialty LLC | $273.02 | 2025 | Tobi Podhaler, Yupelri |
| Sunovion Pharmaceuticals INC. | $263.22 | 2019-2021 | |
| Abbvie INC. | $258.72 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $219.70 | 2021-2025 | |
| Pulmonx Corporation | $213.28 | 2019-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Amgen INC. | $207.39 | 2021-2025 | Tezspire |
| Chiesi USA, INC. | $179.53 | 2019-2021 | |
| Philips North America LLC | $166.85 | 2019-2024 | (6299) Dreamwear, (Di7) Home Pi Undivided |
| Vertex Pharmaceuticals Incorporated | $163.11 | 2019-2022 | |
| Gilead Sciences, INC. | $144.60 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $131.26 | 2020-2025 | Glassia |
| Baxter Healthcare | $115.61 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Astrazeneca Uk Limited | $112.90 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.01 | 2024 | Lifevest |
| Advanced Respiratory, INC | $83.34 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $78.91 | 2022-2025 | |
| Ani Pharmaceuticals, INC. | $78.83 | 2022-2025 | Purified Cortrophin Gel |
| Axsome Therapeutics, INC. | $72.22 | 2024 | Sunosi |
| Shire North American Group INC | $69.42 | 2019 | |
| Inogen, INC. | $69.38 | 2023-2025 | Inogen One G3 Oxygen Concentrator, Inogen One G5 Oxygen Concentrator - Bluetooth |
| Verona Pharma, INC. | $67.38 | 2025 | Ohtuvayre |
| Paratek Pharmaceuticals, INC. | $57.19 | 2021-2023 | Nuzyra |
| Genentech, INC. | $56.05 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $52.52 | 2022-2023 | Airduo Digihaler |
| Csl Behring | $45.43 | 2019-2021 | |
| Avadel Cns Pharmaceuticals, LLC | $43.83 | 2024 | Lumryz |
| Inspire Medical Systems, INC. | $37.73 | 2023-2025 | Inspire |
| Circassia INC. | $37.58 | 2020 | |
| Vifor Pharma, INC. | $35.16 | 2025 | Zemaira |
| Lilly USA, LLC | $31.90 | 2025 | Zepbound |
| Pari Respiratory Equipment, INC. | $31.69 | 2019-2021 | |
| Pfizer INC. | $20.58 | 2019 | |
| Zoll Respicardia, INC. | $19.26 | 2024 | Remede System |
| Abiomed | $18.60 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $17.00 | 2019 | |
| Boston Scientific Corporation | $16.81 | 2019 | |
| Nabriva Therapeutics, Plc | $16.56 | 2020 | |
| Idorsia Pharmaceuticals US INC | $16.04 | 2023 | Quviviq |
| Janssen Pharmaceuticals, INC | $10.41 | 2019 | |
| Veran Medical Technologies, INC. | $5.76 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$4,674.46 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Da Wei Liao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.